Komori
Japan Animal Referral Medical Center (6039) · InitiativeAdvanced

Refinancing and Improved Repayment Terms Through a Syndicated Loan

First written in FY2017. 4 of 6 entries say "Advanced", first in FY2018-Q2. Latest entry: FY2024.

6entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2018-Q1 – FY20242017: 320172018: 120182019: 020192020: 020202021: 020212022: 020222023: 120232024: 12024
Same theme, other companies
Refinancing Existing Borrowings Through a Syndicated Loan and Stabilizing Cash FlowA theme 39 companies write about · 0 as a headwind · 39 as a tailwind

16 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 39 companies compared. The sentences above are computed from all 39.
Full recordFilings, disclosures and news, newest first
  1. FY2024AdvancedAnnual report

    「Commitment amount ¥1,700 million Borrowings drawn ¥1,700 million Undrawn balance —」

    Under the syndicated commitment line, borrowings drawn reached ¥1,700 million, leaving no undrawn balance.
  2. FY2023AdvancedAnnual report

    「Commitment amount ¥1,700 million Borrowings drawn ¥1,450.1 million Undrawn balance ¥249.9 million」

    Under the syndicated commitment line, borrowings drawn increased from ¥924.8 million in the previous fiscal year to ¥1,450.1 million, while the undrawn balance decreased from ¥775.2 million to ¥249.9 million.
  3. FY2018AdvancedAnnual report

    「The Company has entered into a syndicated commitment line agreement with 8 relationship banks to efficiently raise funds. The undrawn balance of borrowings under this agreement at the end of the current consolidated fiscal year was as follows.」

    For the syndicated commitment line, the disclosure states a commitment amount of ¥1,700 million, borrowings drawn of ¥698.7 million, and an undrawn balance of ¥1,001.3 million.
  4. FY2018-Q2AdvancedAnnual report

    「The Company drew down the second tranche under the syndicated loan agreement entered into on 28 June 2017, as described under Subsequent Events in the Important Matters section of the 12th Fiscal Year Securities Report, on 31 October 2017 for capital expenditure financing. ① Lenders: The Bank of Yokohama, Ltd., Mizuho Bank, Ltd. and 6 other banks ② Amount drawn: ¥470 million ③ Interest rate: Benchmark rate (2-month TIBOR) + spread of 0.30% ④ Drawdown date: 31 October 2017 ⑤ Final repayment date: 30 September 2027 ⑥ Collateral: Land and buildings」

    Under the syndicated loan already entered into and refinanced, the Company drew down the second tranche of ¥470 million on 31 October 2017.
  5. FY2018-Q1AchievedAnnual report

    「The Company entered into a syndicated loan agreement with its relationship financial institutions and completed the refinancing of its borrowings to achieve stable, long-term funding, improve borrowing terms and level annual repayments. The refinancing resulted in temporary costs, including arrangement fees and expenses for creating real estate security; however, the expected future reduction in borrowing interest resulting from lower contractual interest rates is expected to exceed these costs.」

    The Company entered into a syndicated loan agreement and completed the refinancing of its borrowings. The disclosure states that, although the refinancing resulted in temporary costs, the expected future reduction in borrowing interest due to lower contractual interest rates is expected to exceed those costs.
  6. FY2017First statedAnnual report

    「The Company resolved at a meeting of the Board of Directors held on 20 June 2017 to enter into a syndicated loan agreement totaling ¥4,332.75 million, including undrawn commitments, with The Bank of Yokohama, Ltd. as arranger and agent and Mizuho Bank, Ltd. as arranger, for the purpose of improving borrowing terms and leveling annual repayments.」

    The Company entered into a syndicated loan agreement totaling ¥4,332.75 million, with a final repayment date of 31 March 2034, to refinance existing borrowings and fund future capital expenditure.
Moved together

"Providing State-of-the-Art Veterinary Care and Achieving Qualitative Growth" moved the same way as this thread, in the same document, in 4 of its 6 moves.

433333★123456
  1. ★This thread
  2. 1Providing State-of-the-Art Veterinary Care and Achieving Qualitative Growth4×
  3. 2Expansion of secondary-care facilities in major cities nationwide3×
  4. 3Expansion and strengthening of the affiliated-hospital network3×
  5. 4Developing and Securing Outstanding Talent3×
  6. 5Target to increase the number of first-time consultations as the most important management metric3×
  7. 6Dilution of Share Value from Stock Options3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Japan Animal Referral Medical Center yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.